11.3 Kentucky Pharmacist Immunization Authority

11.3 Kentucky Pharmacist Immunization Authority

Immunization administration is the most visible clinical public health function Kentucky pharmacy professionals perform, and it is a reliable MPJE topic because Kentucky changed the governing rule recently. The authority sits in two places: the statutory definition of the practice of pharmacy at KRS 315.010(22), and the Board regulation 201 KAR 2:420 (Administration of vaccines), effective October 20, 2021.

1. Statutory Authority, Pathways & the Age-5 Rule

┌─────────────────────────────────────────────────────────────────────────────┐
│              KENTUCKY VACCINE ADMINISTRATION: TWO PATHWAYS                  │
├─────────────────────────────────────────────────────────────────────────────┤
│ PATHWAY 1 — PRESCRIBER-APPROVED PROTOCOL (KRS 315.010(22))                  │
│ • Standing protocol issued by an authorized prescriber, or a statewide      │
│   standing order from the CHFS Department for Public Health.                │
│ • Scope: vaccines on the ACIP standard immunization schedule.               │
│ • AGE FLOOR: FIVE (5) YEARS AND OLDER.                                      │
│ • For a minor: parent or guardian consent is required, AND the pharmacist   │
│   must notify the child's primary care provider.                            │
│                                                                             │
│ PATHWAY 2 — PATIENT-SPECIFIC PRESCRIPTION / MEDICATION ORDER                │
│ • An individual order from an authorized prescriber for a named patient.    │
│ • NO statutory age floor — this is the route for a child under 5, or for a  │
│   vaccine not on the ACIP schedule (e.g., certain travel vaccines).         │
└─────────────────────────────────────────────────────────────────────────────┘

Exam Trap — the age floor moved from 9 to 5. From 2017 until 2024, Kentucky pharmacists could vaccinate under protocol only from age 9, with a temporary COVID-era drop to age 3 that has since expired. 2024 Ky. Acts ch. 11 (House Bill 274) amended KRS 315.010 and KRS 315.205 to set the protocol floor at five (5) years of age, with parent or guardian consent and mandatory notification of the child's primary care provider. Any prep source still printing "9 and older for non-influenza vaccines" is quoting repealed law. A question describing a 6-year-old whose mother consents is asking whether you know the current rule: the pharmacist may vaccinate under protocol.

Who May Physically Administer the Vaccine?

201 KAR 2:420 distributes this authority across three roles, and — importantly — the supervision standard for the delegated roles is general, not immediate:

Exam Trap — "technicians may not vaccinate in Kentucky" is false. Kentucky expressly authorizes registered pharmacy technicians to administer vaccines under 201 KAR 2:420 §4. The technician is the only role with an explicit CE requirement attached to vaccination (2 hours per registration period). Note also that the regulation says general supervision for both interns and technicians — a choice that requires the pharmacist to be "physically present and immediately available" is describing immediate supervision, a stricter standard than 201 KAR 2:420 imposes.

2. Credentialing: What Kentucky Actually Requires of Each Role

Kentucky's vaccine regulation is much shorter than most candidates expect, and the gap between what the regulation requires and what employers require is where items get written.

┌─────────────────────────────────────────────────────────────────────────────┐
│        201 KAR 2:420 CREDENTIALING — WHAT THE REGULATION SAYS               │
├─────────────────────────────────────────────────────────────────────────────┤
│ PHARMACIST (§2):                                                            │
│  • May administer a vaccine pursuant to the ACIP standard immunization      │
│    schedule in accordance with KRS 315.010(22).                             │
│  • The regulation states NO state training certificate, NO state CPR rule,  │
│    and NO immunization-specific CE requirement for the pharmacist.          │
│                                                                             │
│ PHARMACIST INTERN (§3) — under GENERAL pharmacist supervision:              │
│  1. ACPE-accredited practical training program including hands-on injection │
│     technique and recognition/treatment of emergency reactions; AND         │
│  2. Current certificate in basic cardiopulmonary resuscitation.             │
│                                                                             │
│ PHARMACY TECHNICIAN (§4) — under GENERAL pharmacist supervision:            │
│  1. Minimum TWO (2) HOURS of immunization-related continuing education per  │
│     registration period; AND                                                │
│  2. The same ACPE-accredited practical training program; AND                │
│  3. Current certificate in basic cardiopulmonary resuscitation.             │
└─────────────────────────────────────────────────────────────────────────────┘

Where the Real-World Requirements Come From

A pharmacist practising in Kentucky will still, in practice, hold an immunization certificate and current BLS — but the legal source of that obligation matters on the exam:

• The protocol itself. A prescriber-approved protocol may condition the pharmacist's authority on completing training and maintaining CPR certification. Practising outside those terms is a breach of the protocol under which the authority exists, not a violation of 201 KAR 2:420 §2.
• Federal PREP Act declarations. During a declared public health emergency, federal amendments can impose their own training and CE conditions that preempt state law. The COVID-19 PREP Act expansions — including administration down to age 3 — expired with the emergency. Do not answer a current-law question from them.
• General Kentucky CE. A Kentucky pharmacist owes 15 contact hours annually under 201 KAR 2:015, including 1 hour on the opioid epidemic or opioid use disorder for licensing years 2023 through 2028 — but there is no Kentucky immunization CE mandate for pharmacists. The 2-hour immunization CE requirement belongs to technicians only.

Exam Trap — do not import a pharmacist immunization CE rule. Several state boards require pharmacists to complete immunization-specific CE each renewal. Kentucky's Board regulation does not. If an item asks what a Kentucky pharmacist must complete annually, the answer is the general 15 contact hours including 1 opioid hour — not an immunization hour.

Clinical Safety Expectations

Nothing in this section relieves the administering professional of the ordinary standard of care. Every Kentucky immunization site should maintain immediate access to injectable epinephrine (adult and pediatric strengths), a CPR barrier device, and basic vital-sign equipment, and every administrator should be able to distinguish vasovagal syncope (transient fainting, pallor, diaphoresis, bradycardia, normal breathing — place the patient supine and elevate the legs) from anaphylaxis (acute urticaria/angioedema, bronchospasm, stridor, hypotension, tachycardia — give intramuscular epinephrine into the anterolateral thigh immediately and activate 911). Treating anaphylaxis with an antihistamine alone, and withholding epinephrine, is the classic clinical error tested alongside these rules.

3. Operational Protocols, Safety Standards & Emergency Response

Every pharmacy where immunizations are administered must comply with rigorous operational and clinical safety standards:

1. Mandatory Vaccine Information Statements (VIS)

• Under federal law (42 U.S.C. § 300aa-26), the person administering the vaccine must provide the most current CDC Vaccine Information Statement (VIS) to the patient (or parent/legal guardian) prior to the administration of each dose of any vaccine.
• The pharmacy must record the edition date of the VIS and the date the VIS was provided in the patient's permanent immunization record.

2. Pre-Vaccination Screening & Clinical Assessment

• The pharmacist must conduct a thorough clinical screening using a standardized screening questionnaire evaluating:
  • Previous severe allergic reactions (anaphylaxis) to vaccines or vaccine components (gelatin, neomycin, yeast, latex);
  • History of Guillain-Barré Syndrome (GBS) within 6 weeks of previous influenza or tetanus vaccination;
  • Acute moderate to severe illness with or without fever (precaution; defer vaccination until recovered);
  • Live Attenuated Vaccines Screening (e.g., MMR, Varicella, Live Attenuated Influenza Nasal Spray / FluMist, Yellow Fever, Oral Typhoid): Must screen for active pregnancy (live vaccines contraindicated due to theoretical teratogenicity risk) and severe immunocompromised states (HIV with $\text{CD4} < 200\text{ cells/}\mu\text{L}$, active leukemia/lymphoma, solid organ transplant, high-dose systemic corticosteroid therapy $\ge 20\text{ mg/day}$ prednisone equivalent for $\ge 14$ days).

3. Emergency Anaphylaxis Response Kit & Medical Management

Every immunization site must maintain an immediately accessible emergency medical response kit to manage acute life-threatening anaphylactic reactions:

┌─────────────────────────────────────────────────────────────────────────────┐
│                     MANDATORY EMERGENCY RESPONSE SUPPLIES                   │
├─────────────────────────────────────────────────────────────────────────────┤
│ 1. Injectable Epinephrine (First-Line Life-Saving Therapy):                 │
│    • Adult Epinephrine: Auto-injectors (0.3 mg) OR 1 mg/mL (1:1,000)        │
│      vials/ampules with appropriate 1-inch to 1.5-inch IM syringes.         │
│    • Pediatric Epinephrine: Auto-injectors (0.15 mg) for pediatric dosing.  │
│    • Must maintain at least two (2) unexpired doses of epinephrine on site. │
│                                                                             │
│ 2. Diphenhydramine (Adjunctive Second-Line Therapy):                        │
│    • Oral Diphenhydramine (25 mg / 50 mg tablets or oral liquid);           │
│    • Injectable Diphenhydramine (50 mg/mL solution for IM injection).       │
│                                                                             │
│ 3. Auxiliary Emergency Equipment:                                           │
│    • CPR pocket mask / barrier device;                                      │
│    • Blood pressure cuff and stethoscope;                                   │
│    • Alcohol swabs, sterile gauze pads, adhesive bandages, and ice packs.   │
└─────────────────────────────────────────────────────────────────────────────┘

Exam Trap — Vasovagal Syncope vs. Anaphylaxis: Pharmacists must distinguish between vasovagal syncope (transient fainting, pallor, diaphoresis, bradycardia, normal breathing—managed by placing patient supine and elevating legs) and anaphylaxis (acute onset urticaria/angioedema, bronchospasm/wheezing, stridor, hypotension, tachycardia—mandating immediate intramuscular epinephrine into the anterolateral thigh and activating 911).

4. Documentation, Registry Reporting & Adverse Events

1. The Kentucky Immunization Registry (KYIR) — Voluntary, Not Mandated

Kentucky maintains a statewide immunization information system, KYIR, and pharmacies are strongly encouraged to submit to it. But Kentucky does not have a mandate requiring vaccination providers to report immunizations to KYIR — participation is voluntary. No pharmacist reporting deadline of 14 days, 30 days, or any other interval appears in 201 KAR 2:420 or in KRS Chapter 315.

Exam Trap — the invented KYIR deadline. A widely circulated MPJE flashcard claims Kentucky pharmacists must submit vaccine data to KYIR "within 14 calendar days." That deadline is not in the Board's vaccine regulation or its statutes. Do not answer a Kentucky registry question with a number you cannot source. If an item offers "reporting to KYIR is voluntary in Kentucky," that is the defensible answer.

2. Primary Care Provider Notification — This One IS Mandatory

KRS 315.205, as amended by HB 274 (2024), requires a pharmacist who administers a vaccine to a child under the protocol pathway to notify the child's primary care provider. Together with the parent/guardian consent requirement, these are the two statutory strings attached to lowering the protocol age floor to 5, and they are the most testable part of the 2024 amendment.

3. Vaccine Information Statements (VIS)

Under the National Childhood Vaccine Injury Act (42 U.S.C. § 300aa-26), the person administering a covered vaccine must provide the current CDC Vaccine Information Statement to the patient (or parent/guardian) before each dose, and must record the VIS edition date and the date the VIS was provided in the patient's permanent record. This is a federal duty that applies in Kentucky regardless of state law.

4. VAERS Reporting

Also under the NCVIA, the administering provider must report to VAERS:

• any adverse event listed in the VAERS Table of Reportable Events occurring within the specified interval;
• any clinically significant adverse event, including hospitalization, disability, or death; and
• any vaccine administration error (wrong vaccine, wrong dose, wrong route, expired product).

5. Record Retention

Immunization records are pharmacy records, so Kentucky's general five (5) year retention rule applies (201 KAR 2:171, 201 KAR 2:210). Retain:

1. Patient name, date of birth, and address;
2. Date of administration and the authorizing protocol or prescription;
3. Vaccine name, manufacturer, lot number, and expiration date;
4. Route and anatomical site (e.g., IM, left deltoid);
5. VIS edition date and the date it was provided;
6. Identity and license or registration number of the person who administered the dose, and of the supervising pharmacist where the administrator was an intern or technician;
7. Signed consent — including parent or guardian consent for a minor — and the completed screening questionnaire;
8. For a minor vaccinated under protocol, evidence that the primary care provider was notified.

5. Kentucky Immunization Requirements Checklist